1. Home
  2. Author
  3. Jilkova ZM

Jilkova ZM

References (2)

Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678
Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P
Ref : Autophagy , 18 :678 , 2022
Abstract :
PubMedSearch : Brun_2022_Autophagy_18_678
PubMedID: 34740311
Gene_locus related to this paper: human-PPT1

Title : GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-beta1 inhibition - Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042
Author(s) : Bestion E , Jilkova ZM , Mege JL , Novello M , Kurma K , Pour STA , Lalmanach G , Vanderlynden L , Fizanne L , Bassissi F , Rachid M , Tracz J , Boursier J , Courcambeck J , Serdjebi C , Ansaldi C , Decaens T , Halfon P , Brun S
Ref : Ther Adv Chronic Dis , 11 :2040622320942042 , 2020
Abstract :
PubMedSearch : Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042
PubMedID: 32728410